Keywords: Takeda, Envoy Theapeutics, Schizophrenia research, bacTRAP

Takeda in schizophrenia research alliance with Envoy Thera

Article | 11 October 2010

Japan’s largest drugmaker Takeda Pharmaceutical (TSE:4502) has formed a three-year research alliance Envoy Therapeutics, a recently-formed US drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Envoy Therapeutics

Takeda Pharmaceuticals

Go to company listing